Bill Sponsor
Senate Bill 477
115th Congress(2017-2018)
Congenital Heart Futures Reauthorization Act of 2017
Introduced
Introduced
Introduced in Senate on Feb 28, 2017
Overview
Text
Introduced
Feb 28, 2017
Latest Action
Feb 28, 2017
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
477
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Illinois
Democrat
Delaware
Republican
Indiana
Democrat
Minnesota
Republican
Mississippi
Democrat
Pennsylvania
Democrat
Rhode Island
Democrat
Wisconsin
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Congenital Heart Futures Reauthorization Act of 2017

This bill amends the Public Health Service Act to replace the authorization for a National Congenital Heart Disease Surveillance System with a requirement for the Department of Health and Human Services, regarding congenital heart disease, to enhance and expand research and surveillance infrastructure, and to plan and implement a public outreach and education campaign. (Congenital heart disease is a condition caused by a heart defect that is present at birth.)

The Centers for Disease Control and Prevention must conduct: (1) a study of congenital heart disease, from birth to adulthood, that considers health care utilization, demographic factors, and outcomes; and (2) an awareness, outreach, and education campaign regarding congenital heart disease. Data from the study must be made available to the public.

The National Heart, Lung, and Blood Institute must report on its ongoing research efforts regarding congenital heart disease, future plans for such research, and areas of greatest need for such research.

Text (1)
February 28, 2017
Actions (2)
02/28/2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1504-1505)
02/28/2017
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:35:50 PM